IVERIC bio Stock Forecast, Price & News

IVERIC bio (NASDAQ:ISEE) Frequently Asked Questions

Is IVERIC bio a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IVERIC bio in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IVERIC bio stock.
View analyst ratings for IVERIC bio or view top-rated stocks.

What stocks does MarketBeat like better than IVERIC bio?

Wall Street analysts have given IVERIC bio a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but IVERIC bio wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is IVERIC bio's next earnings date?

IVERIC bio is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for IVERIC bio.

How were IVERIC bio's earnings last quarter?

IVERIC bio, Inc. (NASDAQ:ISEE) issued its quarterly earnings data on Tuesday, August, 3rd. The company reported ($0.32) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.06.
View IVERIC bio's earnings history.

How has IVERIC bio's stock been impacted by Coronavirus (COVID-19)?

IVERIC bio's stock was trading at $4.46 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ISEE shares have increased by 295.7% and is now trading at $17.65.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for ISEE?

3 Wall Street analysts have issued twelve-month price targets for IVERIC bio's shares. Their forecasts range from $18.00 to $22.00. On average, they expect IVERIC bio's share price to reach $20.00 in the next twelve months. This suggests a possible upside of 13.3% from the stock's current price.
View analysts' price targets for IVERIC bio or view top-rated stocks among Wall Street analysts.

Who are IVERIC bio's key executives?

IVERIC bio's management team includes the following people:

• Glenn P. Sblendorio, Chief Executive Officer & Director
• Pravin U. Dugel, President (LinkedIn Profile)
• Keith Westby, Chief Operating Officer & Senior Vice President
• David F. Carroll, Chief Financial Officer, Treasurer & SVP
• Abraham Scaria, Chief Scientific Officer

What is Glenn Spina's approval rating as IVERIC bio's CEO?

6 employees have rated IVERIC bio CEO Glenn Spina on Glassdoor.com. Glenn Spina has an approval rating of 41% among IVERIC bio's employees. This puts Glenn Spina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of IVERIC bio's key competitors?

Some companies that are related to IVERIC bio include Sarepta Therapeutics (SRPT), Arrowhead Pharmaceuticals (ARWR), Legend Biotech (LEGN), HUTCHMED (HCM), Blueprint Medicines (BPMC), Ultragenyx Pharmaceutical (RARE), Allakos (ALLK), Perrigo (PRGO), I-Mab (IMAB), Alkermes (ALKS), Ionis Pharmaceuticals (IONS), TG Therapeutics (TGTX), Mawson Infrastructure Group (WIZP), Cerevel Therapeutics (CERE) and Arvinas (ARVN).
View all of ISEE's competitors.

What other stocks do shareholders of IVERIC bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IVERIC bio investors own include Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Maxar Technologies (MAXR), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Alibaba Group (BABA), Cisco Systems (CSCO) and Kinross Gold (KGC).

What is IVERIC bio's stock symbol?

IVERIC bio trades on the NASDAQ under the ticker symbol "ISEE."

Who are IVERIC bio's major shareholders?

IVERIC bio's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.49%), Avoro Capital Advisors LLC (6.18%), Yiheng Capital Management L.P. (4.86%), Vanguard Group Inc. (4.04%), State Street Corp (3.08%) and Logos Global Management LP (2.40%). Company insiders that own IVERIC bio stock include David R Guyer, Glenn Sblendorio, Keith Westby and Pravin Dugel.
View institutional ownership trends for IVERIC bio.

Which institutional investors are selling IVERIC bio stock?

ISEE stock was sold by a variety of institutional investors in the last quarter, including Avoro Capital Advisors LLC, State Street Corp, Nuveen Asset Management LLC, Ghost Tree Capital LLC, Acuta Capital Partners LLC, BlackRock Inc., Samsara BioCapital LLC, and Citadel Advisors LLC. Company insiders that have sold IVERIC bio company stock in the last year include David R Guyer, Keith Westby, and Pravin Dugel.
View insider buying and selling activity for IVERIC bio or view top insider-selling stocks.

Which institutional investors are buying IVERIC bio stock?

ISEE stock was bought by a variety of institutional investors in the last quarter, including Yiheng Capital Management L.P., Logos Global Management LP, Sphera Funds Management LTD., Morgan Stanley, Morgan Stanley, Millennium Management LLC, Dimensional Fund Advisors LP, and Jefferies Group LLC.
View insider buying and selling activity for IVERIC bio or or view top insider-buying stocks.

How do I buy shares of IVERIC bio?

Shares of ISEE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IVERIC bio's stock price today?

One share of ISEE stock can currently be purchased for approximately $17.65.

How much money does IVERIC bio make?

IVERIC bio has a market capitalization of $1.84 billion. The company earns $-84,550,000.00 in net income (profit) each year or ($1.14) on an earnings per share basis.

How many employees does IVERIC bio have?

IVERIC bio employs 57 workers across the globe.

What is IVERIC bio's official website?

The official website for IVERIC bio is ivericbio.com.

Where are IVERIC bio's headquarters?

IVERIC bio is headquartered at ONE PENN PLAZA 35TH FLOOR, NEW YORK NY, 10119.

How can I contact IVERIC bio?

IVERIC bio's mailing address is ONE PENN PLAZA 35TH FLOOR, NEW YORK NY, 10119. The company can be reached via phone at (212) 845-8200 or via email at [email protected].